CRISPR/Cas9 for genome editing: progress, implications and challenges. - Wikidata - awgldk - TriplyDB

CRISPR/Cas9 for genome editing: progress, implications and challenges.

CRISPR/Cas9 for genome editing: progress, implications and challenges.

http://www.wikidata.org/entity/Q34411191

about

Obesity genetics in mouse and human: back and forth, and back again Tapping Stem Cells to Target AMD: Challenges and Prospects Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference Molecular mechanisms and functional implications of polarized actin remodeling at the T cell immunological synapse Cell-based screening: extracting meaning from complex data.MYBPC1, an Emerging Myopathic Gene: What We Know and What We Need to Learn Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches Pathophysiological Functions of Rnd3/RhoE Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications CRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome Editing Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases Schizophrenia genetics: emerging themes for a complex disorder.Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes.Chromothriptic cure of WHIM syndrome.Target specificity of the CRISPR-Cas9 system.Genome editing strategies: potential tools for eradicating HIV-1/AIDS.A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Application of CRISPR/Cas9 genome editing to the study and treatment of disease.Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.Human pluripotent stem cell models of Fragile X syndrome.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.The dawn of active genetics.Genetic risk factors for spontaneous intracerebral haemorrhage.Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells.Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells.Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists.

P2860

Q26782027-ADC61510-63E8-4B46-BEC3-7BD136306388 Q26799625-30E3612D-72D4-408E-950D-0B06CD7C9F4F Q26852489-087F25E4-C614-4481-AFE5-BD76D5324420 Q27026215-C1905555-8B6F-4C19-A7B4-4C71F2EB8C89 Q27305816-BB513739-EDAD-4FC6-A470-70417AA0C83C Q28070076-3FB72A60-1239-48D9-8F65-FBA35709F0EE Q28077396-A9AC12D0-F455-43D6-A99F-B085FF4222E3 Q28078292-0B5CE0F0-BC88-4219-B4F8-45E2DBFA01C6 Q28079111-E23DBE61-3272-43A5-AFDB-99BCE3F50AF4 Q28079519-5C890F64-1499-403D-817E-78B458D82E6C Q28941787-ED464190-B871-4FB4-9B7B-A0D280851D69 Q33591384-413D096A-D213-425D-A4BE-A933B49E22D2 Q33768720-CDE6C8F4-D658-4483-9E36-E42D02967B47 Q33830117-284AFDEF-C745-49D0-8D53-BFEF7AB66CC6 Q34043840-E2696BB3-65B1-40DB-BD18-4CC8C82CE39D Q34045952-7059F5E3-2793-45B1-8EA4-2D7F542CBB68 Q34200828-33741E5C-9E10-4D78-8322-CEAD68F6DB60 Q34447169-10450CE1-0143-4B1B-B52F-5B8C2780AE31 Q35007531-E15F077D-F431-48D4-8DD6-9332BCADC605 Q35065772-59F46A43-28C0-4D1E-8FD6-AAB12D0EF7B9 Q35085186-C955D79B-AF10-4BEA-8DC9-5ABBF59D1D7B Q35114320-3640A4C1-CC52-48BD-9D65-1DE8D2970682 Q35612053-1BCA0F2C-9F29-4D33-B4F0-8B05F0D42742 Q36293232-44E12ADC-50DA-49DC-81F6-0760F5BFDD07 Q37201993-D3D0C756-56DF-4C2D-951E-F6F504A7FF1E Q37430773-C6082E93-315D-4814-99EF-6D3864DC4A5B Q37642712-38EF1A27-FE85-400F-9E85-50EAD81D4AC2 Q37714431-FCC11AE7-D556-4592-9419-D9144EBCE653 Q38397580-2FC84AA4-9A65-4B0F-82A3-D0C09B3ECE4C Q38566445-3EFC6537-7B95-42F2-968A-4F3D738C26E5 Q38660520-1AABA1F2-55C6-49B3-8862-524A6C57E1C5 Q38666481-E695DA6B-8FE3-43B3-AA68-68718B45C8A1 Q38667483-7ADA94FA-2673-4DAC-9CA7-0F72654FCFD8 Q38670107-0ED19AF1-D2A5-4819-BC5E-341819058131 Q38723195-B2C5727B-E32B-4DC9-8F16-A025B7710938 Q38751441-768AB43A-3268-4ECA-8E5E-525DD2EAFEB4 Q38765066-A9D2CD26-BD86-40E3-9D91-5854A7D5FE2E Q38784917-831B1DE6-BB5E-447F-A55E-D01A7D5FCC76 Q38788187-BA92EE72-B03A-4FDD-8B5A-E574AA73BF6C Q38868478-F4F95F39-9626-43CD-A7F3-98B45022F03A

P2860

CRISPR/Cas9 for genome editing: progress, implications and challenges.

http://www.wikidata.org/entity/Q34411191

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@ast

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@en

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@nl

type

label

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@ast

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@en

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@nl

prefLabel

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@ast

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@en

CRISPR/Cas9 for genome editing: progress, implications and challenges.

@nl

P1433

Q34411191-9C0B5C83-99FE-4CE8-984D-0AB0FBEA67A1

P1476

Q34411191-5BEFD5EE-0DE5-4992-9EA6-9611BE879994

P2093

Q34411191-1CB81D61-9CB9-4BEE-B8C0-C32C9AA2713E

Q34411191-AD3E0903-86C7-49D3-8181-70CD122DF4E6

P2860

Q34411191-00EEE2D2-38C4-47DA-BCAA-DE9097790B64

Q34411191-05C7FD22-74B1-4E8A-8DE9-E44AA7EB75D0

Q34411191-0868E0CA-CBC2-41E5-8B35-B291EE0A1127

Q34411191-14C56537-F595-4B81-BB63-17504307BCA0

Q34411191-19203ED1-7DDC-4886-955C-C6F75C67C568

Q34411191-1C1CC242-30F6-4B04-AE3B-CC7848E20333

Q34411191-1E4A06C9-0D79-439B-B769-634BC17FC118

Q34411191-26230AB1-51A6-432A-95DC-D5F3AC79B9BE

Q34411191-2863374D-3FC4-42A5-BC7B-6B9FB6C14068

Q34411191-2B081249-A6F4-40D9-A094-088E5E845A98

P304

Q34411191-AB6F82D1-A136-4DD7-9AF3-7ADF72860596

P31

Q34411191-1FB724CC-5A0A-4110-8CD5-7BE85D2F32E2

P356

Q34411191-34E505C3-C148-4B93-87D7-2AC2B73569C9

P433

Q34411191-47445123-7EDA-4CD4-8495-277C62839204

P478

Q34411191-A1B6B8F3-3DBA-4C0A-B893-9FB0C00BA899

P50

Q34411191-06EF4000-9D03-4DF5-9789-6C155D2D0CCE

P577

Q34411191-4483CF49-B10C-4E14-BA34-A666F8D33463

P5875

Q34411191-53119E71-0992-4F8C-ADEB-C63EE2EBEA3C

P698

Q34411191-B8CF28AE-65C6-42EE-A102-A69E33704E06

P921

Q34411191-70B73B7D-5266-43DA-8B0A-453CFE66D7ED

P356

P1433

Human Molecular Genetics

P1476

CRISPR/Cas9 for genome editing: progress, implications and challenges

@en

P2093

Xiong Guo

http://www.w3.org/2001/XMLSchema#string

Yan Wen

http://www.w3.org/2001/XMLSchema#string

P2860

A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes.

The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

RNA-guided human genome engineering via Cas9

Heritable genome editing in C. elegans via a CRISPR-Cas9 system.

Multiplex genome engineering using CRISPR/Cas systems

Efficient genome editing in zebrafish using a CRISPR-Cas system

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III

RNA-guided editing of bacterial genomes using CRISPR-Cas systems

P304

R40-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU125

http://www.w3.org/2001/XMLSchema#string

P433

R1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260996402

http://www.w3.org/2001/XMLSchema#string

P698

24651067

http://www.w3.org/2001/XMLSchema#string

P921